RRRuiwen Ren

Ruiwen Ren

*This is an algorithmically generated author record based on publicly available information.

Ruiwen Ren has a total of 72 co-authors. Here are the top co-authors by number of shared publications:

  • Jian-Wei Liu

    Western Superconducting Technol Co Ltd, Xian 710018, Shaanxi, Peoples R China

    5 shared publications
  • Mei-Yu Fang

    Department of Microbiology, Center of Disease Control and Prevention of Guangzhou Military Region, Guangzhou, China

    4 shared publications
  • Chunyuan Li

    Center for Disease Control and Prevention of Southern Theater Command

    3 shared publications
  • Yue Chen

    Center for Disease Control and Prevention of Guangzhou Military Command of the PLA, Guangzhou 510507, Guangdong Province, China; Guangdong Arbovirus Diseases Emergency Technology Research Center, Guangzhou, 510507, Guangdong Province, China

    3 shared publications
  • Huacheng Yan

    Guangzhou Military Command Center for Disease Control and Prevention, PLA, Guangzhou 510507, China

    2 shared publications
  • Jianrong Gao

    Center for Disease Prevention and Control of the Southern Theatre Command of the PLA, Guangzhou, China

    2 shared publications

Latest Publications

  • Open Access

    MDV-like endogenous viral elements act as immune rheostats in Aedes cells by modulating defensin A-mediated responses to arboviruses

    by Jie Xiao, Tiantian Wei, Hongzheng Lu, Chunyuan Li, Mei Chen, Peiwen Liu, Xiao-Guang Chen, Zetian Lai, Ruiwen Ren, Jinbao Gu

    Mosquito cell lines are essential tools for arbovirus research. Endogenous viral elements (EVEs) are prevalent in mosquito genomes, yet their functional effects on host immune responses remain unclear, potentially complicating experimental interpretations. In this study, we systematically characterized endogenous mosquito densovirus-like elements (EMLs) within the Aedes aegypti Aag2 cell line and found that these endogenous EMLs are transcriptionally active but translationally defective. The silencing of EML transcripts significantly diminished the replication of Zika virus (ZIKV), Japanese encephalitis virus (JEV), and chikungunya virus (CHIKV), while transiently increasing dengue virus 2 (DENV-2), thereby indicating a virus-dependent regulatory mechanism. Mechanistically, RNA sequencing after EML interference, alongside plasmid-based mimic expression, demonstrated that EML transcripts downregulate defensin A, an antimicrobial peptide produced by mosquitoes. Functional assays using synthetic defensin A showed that this peptide differentially regulates arboviral infection. Binding assays and structural modeling further supported its interaction with viral envelope proteins, while stage-restricted infection assays revealed distinct stages of action: defensin A enhanced adsorption of ZIKV, JEV, and CHIKV, but did not promote DENV-2 adsorption or entry, and instead reduced DENV-2 RNA accumulation at the post-entry replication stage. Our findings highlight a previously unrecognized role of densovirus-derived EVEs in mosquito innate immunity, extending their functional scope from the well-established PIWI-interacting RNA-mediated antiviral defense to the regulation of antimicrobial peptide-associated immune pathways. These findings emphasize the necessity of accounting for EVE activity when analyzing data derived from mosquito cell lines, and suggest that related EVE-mediated immune regulation may contribute to arbovirus dynamics in mosquitoes. IMPORTANCE: Mosquito-borne viruses such as dengue, Zika, Japanese encephalitis, and chikungunya continue to threaten human health worldwide. Laboratory studies often use Aedes aegypti cell lines to investigate how these viruses interact with their mosquito hosts. Here, we show that the genomes of these cells contain endogenous viral elements derived from mosquito densoviruses. Far from being inert fossils, these sequences are transcriptionally active and regulate mosquito immunity by suppressing the antimicrobial peptide defensin A. This immune modulation influences the replication of different arboviruses in opposite ways, enhancing some while restricting others. Our findings reveal that integrated viral elements can shape the outcome of arbovirus infection, with important implications for interpreting mosquito cell culture experiments and for evaluating endogenous viral element-mediated immune regulation in mosquito–virus interactions.

  • Open Access

    Minocycline Inhibits Tick-Borne Encephalitis Virus and Protects Infected Cells via Multiple Pathways

    by Mengtao Cao, Wei Yang, Jintao Yang, Yanli Zhao, Xiaoyu Hu, Xiaoli Xu, Jing Tian, Yue Chen, Hongxia Jiang, Ruiwen Ren, et al.

    Tick-borne Encephalitis (TBE) is a zoonotic disease caused by the Tick-borne Encephalitis virus (TBEV), which affects the central nervous system of both humans and animals. Currently, there is no specific therapy for patients with TBE, with symptomatic treatment being the primary approach. In this study, the effects of minocycline (MIN), which is a kind of tetracycline antibiotic, on TBEV propagation and cellular protection in TBEV-infected cell lines were evaluated. Indirect immunofluorescence, virus titers, and RT-qPCR results showed that 48 h post-treatment with MIN, TBEV replication was significantly inhibited in a dose-dependent manner. In addition, the inhibitory effect of MIN on different TBEV multiplicities of infection (MOIs) in Vero cells was studied. Furthermore, the transcriptomic analysis and RT-qPCR results indicate that after incubation with MIN, the levels of TBEV and CALML4 were decreased, whereas the levels of calcium channel receptors, such as RYR2 and SNAP25, were significantly increased. MIN also regulated MAPK-ERK-related factors, including FGF2, PDGFRA, PLCB2, and p-ERK, and inhibited inflammatory responses. These data indicate that administering MIN to TBEV-infected cells can reduce the TBEV level, regulate calcium signaling pathway-associated proteins, and inhibit the MAPK-ERK signaling pathway and inflammatory responses. This research offers innovative strategies for the advancement of anti-TBEV therapy.


  • Open Access

    A New Auto-RPA-Fluorescence Detection Platform for SARS-CoV-2

    by Jing Tian, Biao Chen, Bin Zhang, Tantan Li, Zhiqiang Liang, Yujin Guo, Huping Jiao, Fenghong Liang, Longquan Xiang, Fanzhong Lin, et al.

    Objective: The outbreak of COVID-19 caused by SARS-CoV-2 has led to a serious worldwide pandemic. Quantitative reverse transcription–polymerase chain reaction (qRT-PCR)–based methods were recommended for routine detection of SARS-CoV-2 RNA. Because the reaction time and analytical sensitivity of qRT-PCR limits the diagnosis of SARS-CoV-2, development of a quick process of SARS-CoV-2 detection technology with high analytical sensitivity remains urgent.Methods: We combined isothermal amplification and fluorescence detection technology to develop a new auto-recombinase polymerase amplification (RPA)-fluorescence platform that could be used in the diagnosis of SARS-CoV-2.Results: By optimization of primers and probes, the RPA platform could detect SARS-CoV-2 nucleotides within 15 min. The limits of detection and specificity of the auto-RPA-fluorescence platform were 5 copies/µL and 100%, respectively. The accuracy of detection of the auto-RPA-fluorescence platform in the 16 positive samples was 100%.Conclusion: The RPA platform is a potential technology for the diagnosis of SARS-CoV-2 infection.


  • Identification of clinical candidates against West Nile virus by activity screening in vitro and effect evaluation in vivo

    by Hailin Tang, Yang Liu, Ruiwen Ren, Yan Liu, Yanhua He, Zhongtian Qi, Haoran Peng, Ping Zhao

    The West Nile virus (WNV) is a member of the flavivirus and is known to cause encephalitis. There is currently no specific treatment for WNV infection. Repurposing of clinically approved drugs appeared promising for rapidly identifying effective, safe, and readily available candidates for antiviral drugs. Here, we screened the small‐molecule compounds with anti‐WNV activity from 978 Food Drug Administration‐approved drugs. Four compounds, including cilnidipine, mycophenolate mofetil, nitazoxanide, and teriflunomide, were found to efficiently abrogate WNV infection in Vero cells and human neuroblastoma SH‐SY5Y cells. The four compounds also exert broad‐spectrum antiviral activity against the Zika virus, Japanese encephalitis virus, yellow fever virus, tick‐borne encephalitis virus, and chikungunya virus. Furthermore, nitazoxanide (a synthetic benzamide) and teriflunomide (an inhibitor of dihydroorotate dehydrogenase, DHODH) protected 20% and 40% of mice from lethal WNV challenge, respectively. Both drugs, which are orally bioavailable and have been approved clinically for many years, may be promising therapeutics for WNV infection. Moreover, the other two DHODH inhibitors, ML390 and vidofludimus, also displayed potent activity against WNV infection in vitro and in vivo.


  • A predominant dengue virus-1 endemic strain and the vector competence of Aedes albopictus from Guangzhou City, China

    by Yue Chen, Jianrong Gao, Liu Yang, Chunyuan Li, Ronghua Chen, Zhenghua Xie, Ruiwen Ren


  • Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus

    by Wang Yang, Huacheng Yan, Yuling Ma, Tiantian Yu, Hongxia Guo, Yuchan Kuang, Ruiwen Ren, Jintao Li


  • Open Access

    A survey of the 2014 dengue fever epidemic in Guangzhou, China

    by Liu Yang, Yue Chen, Huacheng Yan, Pei Zhang, Xiaoli Xu, Boheng Tang, Ping Zhao, Ruiwen Ren

    In 2014, a serious dengue outbreak in Guangzhou occurred, consisting of 37 354 laboratory confirmed cases of infection. In this study, the clinical picture of dengue fever due to dengue virus (DENV...


    • 1 November 2014
      • Vol. 30  (6) , 683-8

    [Research progress in the structure and function of dengue virus non-structural 1 protein].

    by Yue Chen, Rui-Wen Ren, Jian-Wei Liu

    Dengue virus (DENV) is a re-emerging disease transmitted by the Aedes mosquitoes and has become a major public health problem in southern China. Currently, no antiviral drug or effective vaccine exist to control this disease. The chimeric DENV structural protein vaccine cannot elicit balanced levels of protective immunity to each of the four viral serotypes; therefore, non-structural protein components may be required to construct an effective DENV vaccine. The Dengue virus non-structural 1 (DENV NS1) protein plays a critical role in viral pathogenesis and protective immunity. Therefore, immunity to Dengue 1-4 NS1 subtypes may be crucial for the prevention of severe disease. This review attempts to provide an overview about the structure and function of DENV NS1.

    • 1 November 2012
      • Vol. 32  (11) , 1667-70

    [Screening and identification of dengue virus type 2-specific antigens].

    by Ruiwen Ren, Boheng Tang, Pei Zhang, Wenlong Hu, Wenyan Hong, Jianwei Liu

    To screen and identify dengue virus type 2 specific antigens and establish an enzyme-linked immunosorbent assay (ELISA) for detecting dengue virus type 2 antibody. Using the bioinformatic software DNAstar and ANTHEPROT, we analyzed the hydrophilicity, flexibility, surface probability and antigenicity of dengue virus type 1-4, Japanese encephalitis virus, and Yellow fever virus M and E protein amino acid sequences, and also evaluated the influence of secondary structure. The specific epitopes of dengue virus type 2 were predicted according to the epitope location and amino acid sequence similarity, and the epitope conservation was assessed using the sequence information of different dengue virus type 2 strains in GenBank. Based on the results of bioinformatic analysis, 5 specific epitopes were amplified and inserted into the prokaryotic expression vector pET32a, which were transferred into E. coli Rosetta (DE3) for expression of the proteins. SDS-PAGE and Western blotting were used to identify the expressed proteins and test their antigenicities. The antigen selected by Western blotting was used to establish the ELISA system for dengue virus type 2 antibody detection. Bioinformatic analysis predicted 8 possible dengue virus type 2 specific epitopes, and 6 of them were efficiently expressed in E. coli. Western blotting confirmed 1 dengue virus type 2 specific antigen, the ELISA system for dengue virus antibody detection was successfully established using this specific antigen. We have obtained a dengue virus type 2 specific antigen and established an ELISA system for detection of dengue virus type 2 antibody.